Lida Tehrani
25Patents
7h-index
81Co-inventors
72Inventor score
Filing activity: Dec 13, 2002 → Jul 7, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7981893B2 | Heteroaryl compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 73 | Active |
| US8492381B2 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway | Chemistry; Metallurgy | 41 | Active |
| US8110578B2 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway | Chemistry; Metallurgy | 39 | Active |
| US8372976B2 | Methods of treatment comprising the administration of heteroaryl compounds | Chemistry; Metallurgy | 38 | Active |
| US8507492B2 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway | Chemistry; Metallurgy | 18 | Active |
| US8299056B2 | Aminotriazolopyridines, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 18 | Active |
| US7750151B2 | Inhibitors of Akt activity | Chemistry; Metallurgy | 7 | Active |
| US9346812B2 | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 5 | Active |
| US7105548B2 | Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 | Chemistry; Metallurgy | 4 | Expired |
| US9771371B2 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US11634407B2 | Cereblon binding compounds, compositions thereof, and methods of treatment therewith | Human Necessities | 4 | Active |
| US9428509B2 | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 4 | Active |
| US7365074B2 | Pyridazine, pyrimidine and pyrazine ethyne compounds | Chemistry; Metallurgy | 3 | Expired |
| US7268151B2 | Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5 | Chemistry; Metallurgy | 3 | Expired |
| US7462619B2 | Pyridazine, pyrimidine and pyrazine ethyne compounds | Chemistry; Metallurgy | 3 | Active |
| US11739075B2 | Cereblon binding compounds, compositions thereof, and methods of treatment therewith | Human Necessities | 2 | Active |
| US7910561B2 | Inhibitors of Akt activity | Human Necessities | 2 | Active |
| US11560371B2 | Cereblon binding compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 2 | Active |
| US10167290B2 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10683298B2 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11292796B2 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9795607B2 | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 0 | Active |
| US7393959B2 | Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5 | Chemistry; Metallurgy | 0 | Expired |
| US12103920B2 | Cereblon binding compounds, compositions thereof, and methods of treatment therewith | Human Necessities | 0 | Active |
| US12227490B2 | Cereblon binding compounds, compositions thereof, and methods of treatment therewith | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.